Importance of early treatment initiation in the clinical course of multiple sclerosis

Key Points

Key points are not available for this paper at this time.

Abstract

Early treatment initiation was associated with a better clinical outcome. In addition, we confirmed the well-established prognostic factors of late age at onset and early disability.

Mark Helpful

Bookmark

Relay

Mark Helpful

Bookmark

Relay

Cite This Study

Kavaliūnas et al. (Mon,) studied this question.

synapsesocial.com/papers/69d8d84313e0539d74bedc39 https://doi.org/https://doi.org/10.1177/1352458516675039

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Influence of treatments in multiple sclerosis disability: A cohort study2014 · 40 citations
2New diagnostic criteria for multiple sclerosis: Guidelines for research protocols1983 · 7,401 citations
3Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs2012 · 81 citations
4New natural history of interferon‐β–treated relapsing multiple sclerosis2007 · 269 citations
5Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study2007 · 501 citations